Stock & Company Details
West Pharmaceutical Services, Inc. $WST
Price:
N/A
N/A
70M
$28B
52 Week High:
N/A
10 Day Average Volume:
N/A
53.27
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
WST technical indicators
Latest West Pharmaceutical Services, Inc. (WST) indicator readings as of 2026-10-29.
WST's 14-day RSI is 80.8, in overbought territory. At $416.67 it is trading 33.3% above its 200-day moving average of $312.69, and above its 50-day average of $366.43. Price sits above the upper Bollinger Band ($354.09 to $411.60). ADX reads 47.3, indicating a trending market.
WST backtested strategy results
How 4 rule-based strategies performed on West Pharmaceutical Services, Inc. (WST) over recent history, last backtested 2026-10-18. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +20.6% | 44% | 9 | -46.5% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +81.3% | 32% | 25 | -34.9% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +25.6% | 25% | 32 | -38.1% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +39.8% | 71% | 24 | -19.4% |
Overview
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Finance Bot
Ask your questions
Start by typing a question below.
